Monday, October 19, 2020

DxTerity Diagnostics Launches Home COVID-19 Test

Los Angeles-based DxTerity Diagnostics, a genomics company with a CLIA-license laboratory, announced it has released a new, approved at-home COVID-19 test. According to the company, its new saliva test is designed to detect the virus that causes COVID-19 in both symptomatic and asymptomatic individuals. The company said it has recevied FDA Emergency Use Authorization for its SARS-CoV-2 RT-PCR test, which it is offering under the SafeWorkDx name. The cost of the test, which requires a physician prescription, was not announced. DxTerity is led by founder and CEO Bob Terbrueggen.